Home Assessment of Package Inserts for Diagnostic Kits
Article
Licensed
Unlicensed Requires Authentication

Assessment of Package Inserts for Diagnostic Kits

  • Sandra Secchiero , Laura Sciacovelli , Piero Bonvicini , Martina Zaninotto and Mario Plebani
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 37 Issue 6

Abstract

To assure the quality of service in laboratory medicine, it is necessary to implement a quality system which comprises the entire testing process. The use of quality reagents is an important aspect of the process. Despite the fact that it is the responsibility of the laboratory to ensure the quality of the analytical system (including reagents) and since it is impossible to evaluate all commercial diagnostic kits, the laboratory often depends on statements issued by the manufacturer to select the most appropriate diagnostics for a particular laboratory.

In this study we report the results of the analysis of information provided in 887 package inserts enclosed in the more widely used commercial diagnostic kits, following the Standard for the labelling of clinical laboratory materials of the European Committee for Clinical Laboratory Standards (ECCLS). Only a third of these were in agreement with the guidelines of ECCLS Standard, reporting complete and correct information. We believe that it is necessary to implement a constructive cooperation between manufacturers of diagnostic materials and clinical laboratories to produce a more uniform approach to improvements in laboratory quality assurance.

:
Published Online: 2005-06-01
Published in Print: 1999-06-01

Copyright © 1999 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Meetings and Awards
  2. Are Cardiac Troponins the Myocardial Markers for the New Millenium?
  3. Leukocyte Activation Markers in Clinical Practice
  4. Hepatitis C Virus-Specific DNA Sequences in Human DNA: Differentiation by Means of Restriction Enzyme Analysis at the DNA Level of Healthy, Anti-HCV-Negative Individuals
  5. Characterization of Monoclonal Antibodies to Human Protein 1/Clara Cell 10 Kilodalton Protein
  6. Rapid Analysis of Parathion in Biological Samples Using Headspace Solid-Phase Micro-Extraction (HS-SPME) and Gas Chromatography/Mass Spectrometry (GC/MS)
  7. Semi-Automated Rapid Isoelectric Focusing of Apolipoproteins C from Human Plasma Using PhastSystem™ and Immunofixation
  8. The c-erbB-2 Oncogene Amplification by Competitive PCR in Aneuploid Cell Clones Flow Sorted from Breast Cancer Samples
  9. The Index of Individuality Is Often a Misinterpreted Quantity Characteristic
  10. Assessment of Package Inserts for Diagnostic Kits
  11. External Quality Assessment in Clinical Chemistry: Review of the Situation in Croatia with Particular Reference to Equipment
  12. Point-of-Care Testing: the Views of the Working Group of the Dutch Association of Clinical Chemistry
  13. Preliminary Evaluation of the New Hematology Analyzer COULTER® GEN•S™ in a University Hospital
  14. Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage
  15. Oxidative Stress in Skeletal Muscle. A.E. Rezuick, L. Packer, C.K. Sen. J.O. Hollosey and M.J. Jackson, editors
  16. Handbook of Lipoprotein Testing. N. Rifai, C.G. Warnick and M.H. Dominiczak, editors
  17. Erratum: Matthias Oberhoffer, Heinz Vogelsang, Stefan Rußwurm, Thomas Hartung and Konrad Reinhart. Outcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsis
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.1999.103/html
Scroll to top button